The best time to take Mavakatai (Mafantuo) and suggestions for matching it with diet and rest

Mavacamten is a new oral myosin inhibitor mainly used to treat hypertrophic cardiomyopathy (HCM), especially in patients with symptomatic left ventricular outflow tract obstruction. It reduces excessive myocardial contraction by regulating the activity of myocardial contractile proteins, thereby improving heart pumping function and exercise endurance, and alleviating angina, dyspnea and fatigue symptoms. The correct taking time and reasonable lifestyle habits have an important impact on the efficacy and safety of drugs.

It is clinically recommended that patients take Mavacartide orally at a fixed time every day. The recommended dose is 5mgonce a day to maintain stable blood concentration. It is usually recommended to take it in the morning or before and after dinner according to the guidance of a doctor. Fixed medication taking time can reduce blood drug fluctuations, help maintain efficacy, and reduce the risk of cardiovascular adverse reactions. The choice of medication time should be determined based on the patient's daily routine and the doctor's assessment of cardiac function.

Mavaceta can be taken with or without food, but it is recommended to avoid taking it with high-fat or large amounts of food to avoid affecting drug absorption or delaying its onset of action. Drinking enough water helps the medication to be swallowed and absorbed smoothly. Also, avoid caffeinated or alcoholic beverages to reduce the adverse effects on the heart from elevated heart rate or blood pressure fluctuations.

Patients should maintain a regular schedule while taking the medication, ensure adequate sleep and moderate exercise, and avoid strenuous physical activity and mental stress. Regular monitoring of cardiac symptoms and changes in blood pressure and heart rate can help doctors evaluate efficacy and adjust dosage. By scientifically arranging medication time, eating a reasonable diet, and having a good work and rest schedule, patients can maximize the therapeutic effect of Mavaceta while reducing potential risks.

Reference link:https://www.drugs.com